MassMutual Private Wealth & Trust’s Teva Pharmaceuticals TEVA Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-26	Closed	-$458	–	974
2017 Q3	$458	Hold	26	–	–	﹤0.01%	1000
2017 Q2	$864	Sell	26 -454	-95%	-$14.1K	﹤0.01%	948
2017 Q1	$15.4K	Hold	480	–	–	﹤0.01%	630
2016 Q4	$17.4K	Buy	+480	New	+$19.2K	﹤0.01%	437
2016 Q2	$34.2K	Sell	680 -1,530	-69%	-$81.5K	﹤0.01%	425
2016 Q1	$118K	Buy	2,210 +2,030	+1,128%	+$119K	0.02%	321
2015 Q4	$11.8K	Sell	180 -558	-76%	-$34.5K	﹤0.01%	465
2015 Q3	$39.7K	Sell	738 -292	-28%	-$18.9K	0.01%	394
2015 Q2	$54K	Buy	1,030 +767	+292%	+$47.3K	0.01%	358
2015 Q1	$16.4K	Sell	263 -75	-22%	-$4.36K	﹤0.01%	443
2014 Q4	$19.4K	Sell	338 -400	-54%	-$22.3K	0.01%	337
2014 Q3	$39.7K	Buy	738 +108	+17%	+$5.72K	0.01%	385
2014 Q2	$33K	Hold	630	–	–	0.01%	258
2014 Q1	$33.3K	Sell	630 -10	-2%	-$462	0.02%	230
2013 Q4	$25.7K	Buy	+640	New	+$25.2K	0.02%	227

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

MassMutual Private Wealth & Trust's TEVA Position: Q4 2017 in Review

MassMutual Private Wealth & Trust sold out of Teva Pharmaceuticals (TEVA) in Q4 2017, closing a stake of 26 shares — an estimated $458 sold.

MassMutual Private Wealth & Trust first reported a position in TEVA in Q4 2013 and held it in 15 quarters. The position peaked at $118K in Q1 2016. 507 funds tracked by Wall St. Rank hold TEVA as of Q4 2017.

MassMutual Private Wealth & Trust reported no remaining Teva Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
MassMutual Private Wealth & Trust sold 26 Teva Pharmaceuticals shares in Q4 2017, an estimated $458.
MassMutual Private Wealth & Trust first reported a position in Teva Pharmaceuticals in Q4 2013 and held it in 15 quarters.
MassMutual Private Wealth & Trust's Teva Pharmaceuticals position peaked at $118K in Q1 2016.
507 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2017.

Based on MassMutual Private Wealth & Trust's 13F filing for Q4 2017, filed 21 Feb 2018.